The inVentiv Health Podcast Series dissects some of the most complex issues biopharma leaders are facing today. inVentiv’s clinical and commercial experts provide time-tested solutions, as well as perspectives on the news of the day. Hosted by Jeff Stewart, a long-time industry consultant who has advised biopharma leaders on licensing, mergers and acquisitions, pricing and market access, commercialization and go-to-market strategies, each episode explores the challenges and considerations involved with bringing biopharmaceuticals to the market.
About Your Host
Jeff Stewart, Director, inVentiv Health Consulting
Jeff currently advises clients of inVentiv Health Consulting's Pricing & Market Access and Commercial Strategy & Planning Practices. Over the past decade, Jeff has served several roles in the organization, including a term as Head of Search and Evaluation for the firm's parent company, inVentiv Health, where he was responsible for identifying and conducting diligence on all investment partnerships. Jeff was the first to publish the rNPV methodology that is now the most-used valuation method in the industry, and has been working in pharmaceutical valuation for the past 15 years, performing corporate strategy work for nearly all of the top-10 pharmaceutical companies. Prior to joining inVentiv Health Consulting, Jeff served as Vice President, Business Development for Caldera Pharmaceuticals. Previous positions include Business Development Executive at Los Alamos National Laboratory and Owner/Operator at Clinical Capital Group. Jeff earned an MBA from the University of Notre Dame, an MA in molecular biology from Princeton University, and a BS in molecular biology from Brigham Young University.